by synergycap1 | Jun 9, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
The stock market could be characterized as a bull market plagued by “recurring anxiety attacks,” strategist Ed Yardeni told CNBC on Friday. “I’ve kept a diary of these things since March 2009. There’ve been 56 anxiety attacks. Some were...
by synergycap1 | Jun 9, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Working Capital
The Chicago Transit Authority is calling the project “historic.” One thing is for certain. Two things actually. The public transit system’s latest modernization project will be big. And it will eliminate a major rail system bottleneck that has been...
by synergycap1 | Jun 9, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
WASHINGTON (Reuters) – U.S. Commerce Secretary Wilbur Ross is likely to impose a new sugar trade deal with Mexico even if final revisions to it fail to win support from the U.S. industry, trade lawyers and experts say.
by synergycap1 | Jun 9, 2017 | Bad Credit Loans, Bank Lending, Business Loans, Capital, Non-Bank Loans, Working Capital
Reader Resource Apply now to be an Entrepreneur 360™ company. Let us tell the world your success story. Get Started » From finding a job to supporting yourself, graduates are faced with a number of “real world” challenges that are new to them....
by synergycap1 | Jun 9, 2017 | Bad Credit Loans, Bank Lending, Business Loans, Capital, Non-Bank Loans, Working Capital
When the weekend rolls around, many of us can admit to staying up later and sleeping in longer than usual. Because hey, that’s what weekends are for, right? Turns out, you might want to think twice before turning into a night owl on the weekends. If you’ve...
by synergycap1 | Jun 9, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
Two gene-editing companies are hitting back at a scientific publication that caused their stocks to plummet last week, calling it wrong, filled with errors, and saying it shouldn’t have been published. Recommended for You In separate letters sent to Nature...
